Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TiUltra Implants and Xeal Abutments

K-Number: K202344 · 2020-11-16

Decision Date2020-11-16
Product CodeDZE
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

TiUltra Implants and Xeal Abutments is the device name listed in this FDA 510(k) record. The listed applicant is Nobel Biocare AB. It received FDA 510(k) clearance on 2020-11-16 under 510(k) number K202344. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TiUltra Implants and Xeal Abutments?

TiUltra Implants and Xeal Abutments is a medical device that received FDA 510(k) clearance on 2020-11-16. The listed applicant is Nobel Biocare AB. The 510(k) number is K202344.

When did TiUltra Implants and Xeal Abutments receive FDA 510(k) clearance?

TiUltra Implants and Xeal Abutments received FDA 510(k) clearance on 2020-11-16, under 510(k) number K202344.

Who is the listed applicant for TiUltra Implants and Xeal Abutments?

The FDA 510(k) record lists Nobel Biocare AB as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TiUltra Implants and Xeal Abutments?

The FDA product code for TiUltra Implants and Xeal Abutments is DZE.

Other records listing Nobel Biocare AB as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 40 devices →

Related Devices (Code: DZE)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.